Healthcare Stocks: Thursday's Intraday Movement and Market Cap

AquaBounty Techs AQB shares rose 36.4% to $1.24, Tharimmune THAR stock moved upwards by 22.27% to $6.07, and Canopy Growth CGC stock rose 21.19% to $1.83. Losers included Outlook Therapeutics OTLK, Moleculin Biotech MBRX, TNF Pharmaceuticals TNFA, CEL-SCI CVM, SciSparc SPRC, and Apollomics APLM, with declines ranging from 24.72% to 55.8%.

July 02, 2025 - AquaBounty Technologies (AQB) and Tharimmune (THAR) stocks experienced notable price movements today. AquaBounty Technologies' shares rose by 36.4% to $1.24, while Tharimmune's stock moved upwards by 22.27% to $6.07. These significant gains come amidst broader market volatility and varying investor sentiment.

AquaBounty Technologies, which focuses on genetically modified salmon, saw its stock surge despite the lack of major news releases. The company reported a narrowed net loss of $3.4 million in Q2, but its cash reserves remain razor-thin at $730,000, indicating liquidity challenges. The stock's volatility follows its Q2 earnings report and underscores the critical need for asset sales and strategic alternatives for its halted Ohio farm project [1].

Tharimmune, a biotech company, experienced an extraordinary one-day price swing of 36.6%, closing at a massive gain despite the absence of any major fundamental news. This sharp move was attributed to high volume and peer divergence, suggesting algorithmic/retail-driven momentum rather than sector trends. The lack of order-flow data confirms no clear trigger, highlighting artificial price spikes in low-liquidity small-cap stocks [2].

While AquaBounty and Tharimmune saw significant gains, other biotech stocks faced declines. Outlook Therapeutics (OTLK), Moleculin Biotech (MBRX), TNF Pharmaceuticals (TNFA), CEL-SCI (CVM), SciSparc (SPRC), and Apollomics (APLM) all experienced losses ranging from 24.72% to 55.8%.

Investors should closely monitor these price movements and consider the underlying fundamentals and catalysts driving these stocks. The recent volatility underscores the importance of due diligence and a balanced investment approach.

References:
[1] https://www.valuethemarkets.com/analysis/aquabounty-technologies-stock-aqb-financial-challenges-ahead
[2] https://www.ainvest.com/news/tharimmune-thar-surges-36-6-deep-dive-unusual-intraday-activity-2508/